Insider · CIK 0001850679
Judith S Schrecker
Files at CLIR (ClearSign Technologies Corp). First filing -, latest -.
In brief
Judith S Schrecker files SEC Form 4 as director at CLIR (ClearSign Technologies Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Judith S Schrecker has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | CLIR ClearSign Technologies Corp | AGrant or award Restricted Stock Unitsderivative | +46,296 | $0.00 | $0 | 431,957 | Jul 3, 2025 |
| Apr 1, 2025 | CLIR ClearSign Technologies Corp | AGrant or award Restricted Stock Unitsderivative | +33,735 | $0.00 | $0 | 385,661 | Apr 3, 2025 |
| Jan 2, 2025 | CLIR ClearSign Technologies Corp | AGrant or award Restricted Stock Unitsderivative | +18,794 | $0.00 | $0 | 351,926 | Jan 6, 2025 |
Questions about Judith S Schrecker
Answered from the filings on this page, as of the latest one.
Is Judith S Schrecker buying or selling?
Judith S Schrecker has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Judith S Schrecker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Judith S Schrecker has 0.
Where does Judith S Schrecker file Form 4?
Judith S Schrecker has filed Form 4 at CLIR (ClearSign Technologies Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.